RPG Life Sciences share news and announcements
NSE: RPGLIFEBSE: 532983Pharmaceuticals & BiotechnologySmall Cap
Last close ₹2,619.60down ₹160.60 (5.78%)BSE ₹2,618.15
Share price at the NSE close on 23 Oct 2026. Previous close ₹2,780.20.
52-week range of traded prices to 23 Oct 2026
₹1,733.00Low, 23 Mar 2026₹3,127.80High, 25 Sep 2026
- Next results date: the board meets on 29 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹4,333 Cr923rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 28 Jul 2026
- 36.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 Apr 2026
- 7.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.92%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 28 Jul 2026
- 21.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 28 Jul 2026
- 21.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 Apr 2026
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 19,53144.4% delivered
RPG Life Sciences share news and announcements
679 announcements, routine notices left out, newest first. Page 10 of 14.
Mar 2017
1 Mar · Registrar & Share Transfer Agent Update
Feb 2017
Jan 2017
6 Jan · Legal
The exchange asked on 5 Jan 2017
Dec 2016
Nov 2016
Oct 2016
Jul 2016
29 Jul · Regulation 44(3) of SEBI (LODR), Reg., 2015
27 Jul · Legal
Exchange has sought clarification from RPG Life Sciences Limited with respect to announcement dated 27-Jul-2016, regarding (a) appointment of Mr. Yugal Sikri as an Additional Director of the Company. (b) Resignation of Mr. Sachin Raole- CFO & Sr. VP Corporate Services and appointment of Mr. Mahesh Narayanaswamy as Vice President Finance of the Company with effect from July 1, 2016. On basis of above you are required to clarify following -1. Reason for change viz. appointment, resignation, removal, death or otherwise;2. Date of appointment/cessation (as applicable) & term of appointment;3. Brief profile (in case of appointment);4. Disclosure of relationships between directors (in case of appointment of a director).The response of the Company is awaited.
Jun 2016
May 2016
Apr 2016